Enabling Federated Drug Design
Qubigen can assist pharmaceutical companies in shortening the drug development process by generating better candidates, faster, saving both time and money. Alternatively, our Data Access Partners have the opportunity to participate in collaborative projects to help design novel medicines that no single company could develop on their own.
Data Access
Partners
By combining our unique drug design technology with data from diverse partners for a novel target, together we can truly break barriers in this critical field of medicine. Using a Royalty Agreement model, Data Access Partners enjoy the upside of contributing their data to a larger mission, potentially enabling the development of medicines that no single company could have generated on their own.
Qubigen offers the unique opportunity to make use of our large, proprietary database to help develop better candidates faster and more economically. In cases where you wish to use your own, proprietary data to design candidates for a specific private project, we can facilitate the generation of novel candidates, virtually screen candidates using MM and QM, and provide associated analytics to help speed up SAR evaluation, drastically reducing time and resources at this stage of the drug development journey.
